The Potential Role of Dietary Antioxidant Capacity on Age-Related Macular Degeneration
NCT03326401 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2017-11-01
Summary
Including eye health, nutrition plays a vital role for the sustainability of individuals health life. There is an increasing global concern about the issues related with eye health. In 2010, in order to take attention to these issues, World Health Organization (WHO) defined the main reasons of vision disorders as refraction defects of eye diseases (43 %), cataract (33 %), glaucoma (2 %), age-related macular degeneration (AMD) (1 %), diabetic retinopathy (1 %) and undetermined natural reasons (18 %). This report also stated the three biggest reasons of blindness as cataract (51 %), glaucoma (8 %) and AMD (5 %).
AMD is a multi-factorial disease in which the genetic predisposition plays important role with environmental factors and metabolic conditions, except for age. Especially cigarette is the secondary important risk factor for dry-type AMD. In the Age Related Eye Disease Study (AREDS), it was stated that AMD prevalence is higher in white races, compared with races which are not white. At the same time, AREDS searched the effect of diet supplements on the progression of AMD disease. In terms of the patients followed for six years, it was reported that the formulation C and E vitamins, beta carotene and zinc decreased the progression risk of AMD from middle levels to advanced levels by 34 %. In AREDS-2 study completed in 2012, it was shown that the extraction of beta carotene from the formulation and the decrease of zinc did not affect the progression rate of the disease. In the group using beta carotene, including persons who were used to smoke but gave up at least one year ago, the rate of becoming lung cancer was observed as substantially high. Moreover, the use of lutein and zeaxanthin instead of beta carotene in the formula did not increase the risk of lung cancer. In addition, it was shown that omega-3 fatty acids did not decrease risk progression.
In current data, the effect of the intake of carotenoid and antioxidant increased with diet on AMD is not coherent. Likewise, the epidemiological evidences about the relation between diet fat intake and AMD are contradictory. The consumption of fatty fish is related with increased poly-unsaturated fatty acid intake and decreases the risk of AMD. However, it was reported the high rate of total fat intake in other studies as risk factor for AMD. In another study, there was not any important relation found between diet fat intake and AMD occurrence after the correction of other variables. In the interventional AREDS-2 study, it was reported that the additional intake of long-chain omega-3 poly-unsaturated fatty acids did not have any beneficial effect.
The pathophysiological mechanism responsible from the possible relation between obesity and AMD is not clearly known. There are various hypotheses about how obesity causes AMD. In the first hypothesis, obesity can cause AMD after obesity increases systematic oxidative stress. In the second hypothesis, obesity can play a role in AMD pathophysiology as the cause of hyperleptinemia. The studies also prescribed that inflammation could play a role in the progression of AMD and also showed that plasma fibrinogen and other inflammation indicators could be related with late AMD. In Pathologies Oculaires Liées à l'Age (POLA) study made with the participation of many Europeans, it was observed that the progression of late AMD increased by two times in obese individuals and in early AMD, obesity did not affect the progression of disease. In the treatment of this disease which have age-related progression, proper nutrition, vitamin/mineral/supplement usage and the development of precautionary strategies play an important role.
When compared with Body Mass Index (BMI), it was found that the measure of abdominal obesity (waist/hip rate and waist circumference) was the better determinant of chronic diseases such as diabetics and cardiovascular disease. Some evidences in the United States of America indicated that the relation between waist/hip rate and AMD gave stronger results when compared with the relation between BMI and AMD. For middle age cohort, after six years of follow-up, a group of researchers reported that the decrease of waist/hip rate also decreased the risk of AMD and the results were the same for waist circumference, even if the evidences were weak. In another study, it was reported that the increase of waist/hip rate or waist circumference also increased the progression of AMD.
This study was planned with the aim of determining the occurrence of AMD by evaluating dietary total antioxidant capacity, diet components and some anthropometric measures of individuals having age related macular degeneration (AMD). In the study, the possible effect of nutrition on the occurrence of disease was evaluated by comparing healthy individuals with dietary total antioxidant capacity and some anthropometric measures of individuals with AMD.
Conditions
- Age Related Macular Degeneration
Sponsors & Collaborators
-
Hacettepe University
lead OTHER
Principal Investigators
-
F.Gülhan Samur, Ass. Prof. · Hacettepe University
-
Sibel Kadayıfçılar, Prof. · Hacettepe University
-
Sedat Arslan, RA · Hacettepe University
Eligibility
- Min Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-07-01
- Primary Completion
- 2015-10-01
- Completion
- 2016-02-20
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Effects of Lutein and Zeaxanthin Supplementation on Early Age-related Macular Degeneration
NCT01528605 ·Status: COMPLETED ·Phase: NA
-
Morpho-functional Changes After Oral Supplementation of Antioxidants and Anti-inflammatory Treatment in Age-Related Macular Degeneration.
NCT03919019 ·Status: COMPLETED ·Phase: NA
-
Effects of Antioxidants on Human Macular Pigments
NCT00718653 ·Status: COMPLETED ·Phase: NA
-
Lutein for Age-Related Macular Degeneration
NCT00006202 ·Status: COMPLETED ·Phase: PHASE2
-
Regional Kale as Source of Lutein and Zeaxanthin to Improve Vision of AMD-patients
NCT02136303 ·Status: UNKNOWN ·Phase: NA
-
Effects of Sea Buckthorn Oil and Lutein on Eye Health
NCT02379169 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Eggs and Egg Products on Macular Pigment
NCT00527553 ·Status: COMPLETED ·Phase: NA
-
Age-Related Eye Disease Study 2 (AREDS2) 10-year Follow-On
NCT03367767 ·Status: COMPLETED
-
Therapeutic Potential of Omega-3 Fatty Acids Supplementation in Dry Macular Degeneration and Stargardt Disease
NCT03297515 ·Status: COMPLETED ·Phase: NA
-
Carotenoid Supplementation and Normal Ocular Health
NCT02147171 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Omega-3-fatty Acids on Age-related Macular
NCT01258335 ·Status: COMPLETED ·Phase: NA
-
Vitamin A Palmitate Supplementation in People With Age-Related Macular Degeneration (and Without Reticular Pseudodrusen) and Delayed Dark Adaptation
NCT03478865 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Lutein/Zeaxanthin and Omega-3 Supplementation in Persons Over Age 60
NCT00121589 ·Status: COMPLETED ·Phase: PHASE1
-
Oxidative Stress in Patients With Age-Related Macular Degeneration
NCT00465400 ·Status: COMPLETED
-
Drusen Morphology Changes in Nonexudative Age-related Degeneration After Oral Antioxidants Supplementation
NCT02264938 ·Status: COMPLETED ·Phase: NA
-
Natural History, Pathogenesis, and Outcome of Ocular Disorders
NCT02821767 ·Status: RECRUITING
-
Dark Adaptation in Participants With Age-Related Macular Degeneration
NCT03225131 ·Status: ACTIVE_NOT_RECRUITING
-
Effect of Micronutrient Supplementation on the Intestinal Microbiota in Patients With Age-related Macular Degeneration - The Gut-Retina-axis Study
NCT06391411 ·Status: COMPLETED ·Phase: NA
-
The Role of Macular Pigment in Patients With Age-related Macular Degeneration
NCT00494325 ·Status: COMPLETED
-
Possible Effects of Supplement Therapy With Oral Phenolics on Cluster of Differentiation 163 (CD-163) Biomarker of Patients With Age-related Macular Degeneration
NCT05005884 ·Status: UNKNOWN ·Phase: PHASE1
-
Effect of Omega-3-fatty Acids on Blood Levels Omega-3 Fatty Acids in Patients With Age-related Macular Degeneration
NCT01653184 ·Status: COMPLETED ·Phase: NA
-
Intervention Trial in Early Age-related Macular Degeneration
NCT01694680 ·Status: COMPLETED ·Phase: NA
-
Effect of Carotenoids Supplementation on Visual Function in Chinese Subjects
NCT06098677 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Pistachios and Neural Macular Pigment
NCT05283941 ·Status: UNKNOWN ·Phase: NA
-
Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic Retinopathy
NCT02875704 ·Status: TERMINATED